Vimarsana
Biggest News Aggregation in the World

Page 15 - Pascal Touchon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pascal Touchon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pascal Touchon Today - Breaking & Trending Today

Atara Biotherapeutics (NASDAQ:ATRA) Trading Up 10.4% - Vimarsana News

Atara Biotherapeutics (NASDAQ:ATRA) Trading Up 10.4%

Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating)’s stock price was up 10.4% during mid-day trading on Tuesday . The stock traded as high as $6.49 and last traded at $6.48. Approximately 34,361 shares traded hands during trading, a decline of 97% from the average daily volume of 1,117,919 shares. The stock had previously closed at […]

Brokerages Anticipate Atara Biotherapeutics, Inc. (NASDAQ:ATRA) to Announce -$0.91 EPS - Vimarsana News

Brokerages Anticipate Atara Biotherapeutics, Inc. (NASDAQ:ATRA) to Announce -$0.91 EPS

Equities research analysts forecast that Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) will post earnings per share (EPS) of ($0.91) for the current quarter, Zacks Investment Research reports. Three analysts have provided estimates for Atara Biotherapeutics’ earnings, with estimates ranging from ($0.97) to ($0.79). Atara Biotherapeutics also posted earnings per share of ($0.91) in the […]

Analysts Anticipate Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Will Announce Quarterly Sales of $8.84 Million - Vimarsana News

Analysts Anticipate Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Will Announce Quarterly Sales of $8.84 Million

Equities analysts expect that Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) will post sales of $8.84 million for the current fiscal quarter, according to Zacks. Three analysts have made estimates for Atara Biotherapeutics’ earnings. The lowest sales estimate is $5.80 million and the highest is $14.73 million. Atara Biotherapeutics reported sales of $3.87 million in […]

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Receives Consensus Rating of "Hold" from Analysts - Vimarsana News

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Receives Consensus Rating of "Hold" from Analysts

Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) has earned an average recommendation of “Hold” from the eight analysts that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company. The […]

FUJIFILM Acquires Cell Therapy Manufacturing Facility from Atara - Vimarsana News

FUJIFILM Acquires Cell Therapy Manufacturing Facility from Atara

A 90,000 ft2 manufacturing facility in Thousand Oaks, CA, is readily expandable with the flexibility to produce both clinical and commercial cell therapies, including allogeneic T-cell and CAR T immunotherapies, according to officials at FUJIFILM Diosynth Biotechnologies, a CDMO. The manufacturing facility complements FUJIFILM’s existing manufacturing operations in College Station, TX, Watertown, MA, and its BioCampus in the UK.